Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Saharan Dust Storm Rained Tiny Mineral Spheres on Switzerland for the First Time

October 13, 2026
Continue Reading
saharan-dust-storm-rained-tiny-mineral-spheres-on-switzerland-for-the-first-time
Posted inBiotechnology

Deep Learning Meets Blockchain: VoteChain Slashes Energy Use in Financial Consensus

October 13, 2026
Continue Reading
deep-learning-meets-blockchain:-votechain-slashes-energy-use-in-financial-consensus
Posted inBiotechnology

First Plasmid Found in Halovibrio Reveals a Mosaic Genome Forged by Gene-Sharing in Salt Brines

October 13, 2026
Continue Reading
first-plasmid-found-in-halovibrio-reveals-a-mosaic-genome-forged-by-gene-sharing-in-salt-brines
Posted inBiotechnology

Semaglutide Delivers 14–17% Weight Loss in Landmark Review, but Gains Fade After Stopping

October 13, 2026
Continue Reading
semaglutide-delivers-14–17%-weight-loss-in-landmark-review,-but-gains-fade-after-stopping
Posted inBiotechnology

AI Learns to Summarize Conversations Without Annotated Examples Using Bridge Domains

October 13, 2026
Continue Reading
ai-learns-to-summarize-conversations-without-annotated-examples-using-bridge-domains
Posted inBiotechnology

Light-powered nanozymes promise programmable catalysis, from cancer therapy to clean water

October 13, 2026
Continue Reading
light-powered-nanozymes-promise-programmable-catalysis,-from-cancer-therapy-to-clean-water
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

patient-derived-tumor-organoids-show-promise-for-personalizing-cancer-treatment
Posted inGenetics

Patient-Derived Tumor Organoids Show Promise for Personalizing Cancer Treatment

July 20, 2026
Immunofluorescent image of colorectal cancer organoids. The nuclei are stained blue, along with staining for γ-H2AX (red), which shows where…
Read More
memory-shaped-by-brain-remodeling-during-adolescence-in-mice
Posted inGenetics

Memory Shaped by Brain Remodeling During Adolescence in Mice

July 20, 2026
Credit: Viaframe/Getty Images The human brain continues developing beyond the teenage years, with crucial changes involving decision-making and emotional regulation…
Read More
Posted inBiotechnology

‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong

July 20, 2026
Axiom Biosciences intends to pursue an IPO on the Hong Kong Stock Exchange (HKEX) followed by a co-listing on the…
Read More
new-e25-million-bioreliance-testing-facility-opens-at-merck-kgaa-global-headquarters-in-germany
Posted inGenetics

New €25 Million BioReliance Testing Facility Opens at Merck KGaA Global Headquarters in Germany

July 20, 2026
The facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical…
Read More
Posted inBiotechnology

Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial

July 20, 2026
A phase 3 trial of Kolon TissueGene’s cell-based gene therapy has missed its co-primary endpoints. With a second late-stage study…
Read More
Posted inMedical Technology

Tempus buys out cancer genomics partner Personalis in $1.5 billion deal

July 20, 2026
Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed…
Read More
Posted inBiotechnology

Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds

July 20, 2026
Scribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million…
Read More
Posted inBiotechnology

BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’

July 20, 2026
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according…
Read More
stockwatch:-lilly’s-up-to-$3.8b-deal-for-ataibeckley-a-good-trip-for-psychedelic-drugs,-analysts-and-investors-agree
Posted inGenetics

StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley a Good Trip for Psychedelic Drugs, Analysts and Investors Agree

July 19, 2026
[Credit: wildpixel / 1306005226 / iStock / Getty Images Plus] It wasn’t too long ago that biopharma giants stayed away…
Read More
Posted inBiotechnology

Latigo preps IPO to fund non-opioid pain drug rival to Vertex’s Journax

July 19, 2026
Latigo Biotherapeutics is preparing to go public in order to bankroll the development of its clinical-stage pipeline of non-opioid pain…
Read More

Posts pagination

Previous page 1 … 349 350 351 352 353 … 375 Next page
You May Have Missed
Posted inMedical Technology

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Posted inMedical Technology

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

Posted inMedical Technology

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Posted inMedical Technology

Adagio Medical kicks off strategic review, trims more than half its staff

Privacy Policy    Terms

Scroll to Top